Clinical significance of serum CER, HA and FT3 in diagnosis of liver fibrosis in chronic hepatitis B patients

• Published in: Jie fang jun yi xue za zhi Vol. 45; no. 6; p. 646
• Main Authors: Li-Ming, Tan, Shu-Hui, Ye, Hua, Lei, Guo, Bin, Yong-Lei, Zhao, Hao-Cheng, Zhang, Ze-Yu Hu, Zi-Chao Cao, Wu, Yang, Ting-Ting Zeng, Yong-Jian, Tian, Jian-Lin, Yu, Li, Hua, Juan-Juan, Chen
• Format: Journal Article
• Language: Chinese
• Published: Beijing People's Military Medical Press 01.01.2020
• Subjects: Clinical significance; Hepatitis; Hepatitis B; Interferon; Liver; Liver cirrhosis
• ISSN: 0577-7402
• DOI: 10.11855/j.issn.0577-7402.2020.06.12

Objective　To investigate the clinical significance of serum ceruloplasmin (CER), hyaluronic acid (HA) and free thyroxine 3 (FT3) in detecting liver fibrosis in patients with chronic hepatitis B (CHB). Methods　One hundred and thirtysix cases of CHB patients, 44 cases of post-CHB cirrhosis patients, 20 cases with HBsAg-positive hepatocellular carcinoma (HCC), and 50 healthy controls were randomly selected from July 2014 to January 2018. Serum CER was detected by immune scattering turbidimetry, and direct chemiluminescence method was used for the detection of HA and FT3, one-way ANOVA analysis or rank sum test was used to compare the levels of serum CER, HA, FT3 and other related indexes between each group and the control group. Analysis of the correlation between CER, HA, FT3 and diagnosis model of liver fibrosis was performed and its results were analyzed using the receiver operating characteristic (ROC) curves. Results　(1) The level of serum CER in severe CHB and decompensated liver cirrhosis group was signif